Mission:

THE MISSION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL IS TO ADVANCE CURES, AND MEANS OF PREVENTION, FOR PEDIATRIC CATASTROPHIC DISEASES THROUGH RESEARCH AND TREATMENT. CONSISTE ... (More)


 www.stjude.org
 |  262 DANNY THOMAS PL Memphis TN 38105-3678

St. Jude Children's Research Hospital, Inc. is headquartered in Memphis, TN, and is a 501(c)(3) organization. EIN: 62-0646012.  Donations are tax-deductible. The IRS' NTEE classification is Hospital, Specialty within the Health - General and Rehabilitative category. The IRS ruling year for tax exemption was 1963.

(Source: IRS Business Master File and Form 990)


...  ...  ...  ...  

Encompass Rating System by Charity Navigator


Charity Navigator’s Encompass Rating System evolves on a quarterly basis as we add new measures and indicators, which we call Beacons. Check back often to see how this organization’s score changes.

Learn about the Encompass Rating System: Announcement | FAQ | Release Notes


Overall Score
BETA

100

out of 100

This charity's score is a passing score.

Do you work for St. Jude Children's Research Hospital, Inc.? Gain access to your rating toolkit.


Looking for this charity in our old design?

Back to Top

...   Finance & Accountability


Charity Navigator evaluates a nonprofit organization’s financial health including measures of stability, efficiency and sustainability. We also track accountability and transparency policies to ensure the good governance and integrity of the organization.


Finance & Accountability Score
BETA

100

out of 100

This charity's score is a passing score

This Beta V1 of Finance Score provides a baseline measure of an organization’s health including the indicators listed in the report below.

This score represents Form 990 data from latest filing year 2018.



Finance & Accountability Rating Highlights

Higher Effect on Score

Board Composition

41/43 Independent

We look for at least 3 board members, with more than 50% of members identified as independent.

Lower Effect on Score

Liabilities to Assets Ratio

2.41%

Charity Navigator looks for a ratio less than 50%.

No Effect on Score

Total Revenue

$980,656,319

Charity Navigator doesn’t evaluate revenue amounts or sources in Beta V1. An organization’s size can affect whether and how we evaluate other indicators.

Back to Top

Finance & Accountability Report

100

of 100 points (BETA)

This beta feature is currently viewable only on desktop or tablet screens. Check back later for updates.

Overview

Overview

The Finance and Accountability Score provides a basic measure for organizational health. At this time, it comprises 100% of a charity's Overall Score.

Program Expense Ratio

94.47%

Higher effect on score

More data  


The Program Expense Ratio is determined by Program Expenses divided by Total Expense (average of most recent three 990s).


For a passing score, Charity Navigator looks for a ratio of 70% or higher. Charities in the 50%-70% range receive zero points for their Program Expense Ratio score. Charities that fall below 50% will receive zero points for both of their financial metric scores, Program Expense Ratio AND Liabilities to Assets Ratio.


Source: IRS Form 990

Board Composition

41/43 Independent

Higher effect on score


Charity Navigator looks for at least 3 board members, with more than 50% of those members identified as independent.


Source: IRS Form 990

Independent Review/Financial Audit

Audited

Higher effect on score


For organizations larger than $1million in total revenue we expect to see that the charity completed an audit.


This indicator is not part of the score for organizations less than $250k in total revenue and is removed from the scoring methodology.


For charities under $1 million but over $250K in total revenue we expect to see that the charity completed an Audit, Review or Compilation.


Source: IRS Form 990

Liabilities to Assets Ratio

2.41%

Lower effect on score


The Liabilities to Assets Ratio is determined by Total Liabilities divided by Total Assets (most recent 990).


Charity Navigator looks for a ratio less than 50%.


Source: IRS Form 990

Website Listed

Listed

Lower effect on score


Charity Navigator looks for a website on the Form 990 as an accountability and transparency measure.


Nonprofits act in the public trust and reporting publicly on activities is an important component


Source: IRS Form 990

Data Sources

IRS Forms 990 are provided courtesy of Foundation Center.

...   Impact & Results


Charity Navigator assesses how well a nonprofit delivers on its mission. To issue an Impact & Results score, we estimate the actual impact a nonprofit has on the lives of those it serves, and determine whether it is making good use of donor resources to achieve that impact.


No Score

We have not issued this nonprofit an Impact & Results score. This does not indicate a positive or negative assessment, only that we have not reached a conclusion for one of the following reasons:

  • The nonprofit is eligible for a score, but we have not yet gotten to scoring it.

  • The nonprofit is eligible for a score, but we have not yet developed the specific algorithms to estimate the impact of the type of service it delivers and so cannot issue a score yet.

  • The nonprofit does not primarily deliver services directly to beneficiaries or it is not reasonable to expect the nonprofit to measure impact for its primary activity. The impact analysis framework that we use is not well suited to these nonprofits.

  • The nonprofit is not heavily reliant on individual donors because beneficiaries fund a majority of its costs or it does not receive any private charitable contributions.

Learn more about how we rate nonprofits.

Do you work at St. Jude Children's Research Hospital, Inc.? Share your impact data to request a score.


Back to Top

Additional Information

Unscored

This beta feature is currently viewable only on desktop or tablet screens. Check back later for updates.

Largest Programs

Largest Programs



St. Jude Children's Research Hospital, Inc. reported its three largest programs on its FY 2018 Form 990 as:


$457,825,537

Spent in most recent FY

51%

Percent of program expenses


PATIENT CARE: THE HOSPITAL PROVIDED 19,202 INPATIENT DAYS OF CARE DURING THE YEAR. OUR BONE MARROW TRANSPLANTATION PROGRAM ACCOUNTED FOR 4,407 OR 23% OF THOSE INPATIENT DAYS. PATIENTS MADE 79,024 CLIN ... (More)


$410,716,516

Spent in most recent FY

46%

Percent of program expenses


RESEARCH: THE CURRENT BASIC SCIENCE AND CLINICAL RESEARCH AT THE HOSPITAL INCLUDES WORK IN GENE THERAPY, CHEMOTHERAPY, THE BIOCHEMISTRY OF NORMAL AND CANCEROUS CELLS, RADIATION TREATMENT, BLOOD DISEAS ... (More)


$21,767,276

Spent in most recent FY

2%

Percent of program expenses


EDUCATION AND TRAINING: AS PART OF ITS MISSION, THE HOSPITAL HAS DEVELOPED A GLOBAL INITIATIVE (ST. JUDE GLOBAL) TO IMPROVE THE SURVIVAL RATES OF CHILDREN WITH CANCER AND OTHER CATASTROPHIC DISEASES W ... (More)


GuideStar Seal of Transparency

Gold


GuideStar is Charity Navigator's trusted partner in sharing information on how this organization seeks impact. GuideStar has recognized this organization with a Gold Seal of Transparency for voluntarily and publicly describing their goals, strategies, and accomplishments. Click here for more information.

Note: GuideStar Seals do not effect the nonprofit’s Impact & Results Score.


What is your organization aiming to accomplish?

The mission of St. Jude is to advance cures, and means of prevention, for pediatric cancer and other catastrophic diseases through research and treatment. Specifically we wish to increase the cure rates to over 90% for the major forms of childhood cancer and advance research and treatment of specific childhood diseases such as sickle cell disease and pulmonary infectious diseases. When St. Jude opened its doors in 1962, only 20% of children with cancer survived. Today, helped by innovative research at St. Jude, over 80% survive. Consistent with the vision of our founder Danny Thomas, no family ever receives a bill for treatment, travel, housing or food. This allows treatment and research to be conducted at St. Jude in an unsurpassed manner. St. Jude is a world leader in both providing treatment to children and making scientific discoveries that will save the lives of more children in the future.


What are your strategies for making this happen?

St. Jude Children's Research Hospital's strategy is to be highly focused on our mission, and provide a culture and environment in which great doctors and scientists can do their best work - that is why we have been so successful. We are not a typical children's hospital, but instead are a specialty hospital focused on pediatric cancer and life-threatening diseases in children including sickle cell disease and HIV/AIDS. This strategy has enabled us to become a world leader in our fields of study. We conduct basic, translational and clinical research designed to find cures, improve diagnosis, enhance treatment outcomes, and minimize adverse effects of treatment for these diseases. Approximately 90% of cancer patients treated at St. Jude are enrolled on one or more of our research studies. We serve as a global resource by sharing our knowledge and discoveries with health care and scientific research professionals around the world. Integral to the success of the organization is our ability to raise the necessary funds to support the mission and accelerate progress.We make our discoveries and treatment innovations widely available to the global healthcare and research communities. We share the primary data from our research freely with those wishing to use this information for research purposes. This includes the data from our Pediatric Cancer Genome Project (PCGP), the largest effort of its type. We also provide online resources like our PCGP Explore and Cure4Kids websites.


What are your organization's capabilities for doing this?

St. Jude Children's Research Hospital is the first and only National Cancer Institute-designated comprehensive cancer center devolved solely to children. This designation goes to hospitals that are highly advanced in research, treatment and prevention of cancer. The following capabilities help our organization achieve our stated goals.* World class physicians and researchers.* Highly integrated healthcare teams, providing seamless multi-disciplinary care and research, increasing the speed of discoveries and their translation into new treatments.* Cutting edge research and clinical care facilities.* An efficient fundraising organization that ensures the operation of St. Jude, which relies primarily on the philanthropic support of loyal donors, volunteers and partners.* A committed Board of Governors and Directors.* Collaborations with scientists and physicians around the world.


How will your organization know if you are making progress?

When St. Jude opened its doors in 1962, only 20% of children with cancer survived. St. Jude has pioneered a significant number of advances that have been pivotal in increasing survival rates to 80% today. Our goal is to push childhood cancer survival rates to over 90%, and we won't stop until no child dies from cancer. Results of our research are published in peer-reviewed journals at a rate of more than 600 publications per year. Published studies represent one metric from the scientific community that our findings represent important discoveries. This is also a key means by which we share our discoveries freely with scientists and doctors around the world so the benefits of these discoveries can be maximized. St. Jude physicians provide over 200 professional consultations a month to other physicians treating children in all 50 states and around the world, and St. Jude sees over 250 patients a day at our hospital in Memphis, Tennessee.


What have and haven't you accomplished so far?

The most obvious measure of our success are the lifetime of moments we give to children whom we successfully treat. St. Jude has played a significant role in the increased survival for children with pediatric cancer and other catastrophic diseases—not just those we've treated directly, but those who have benefitted from our discoveries. These include: * In 1972, St. Jude achieved a 50% survival rate for patients with acute lymphoblastic leukemia (ALL) through an innovative combination of therapies. At that time, the estimated survival rate was 17% percent. The results revolutionized leukemia treatment worldwide. * St. Jude is credited with the discovery in 1997 that bone marrow transplants from unrelated, genetically matched donors are as effective in treating childhood leukemia as those from patients' siblings who are genetically matched. Currently, St. Jude has the largest pediatric bone marrow transplant program in the country.* In 2006, St. Jude reported 94% survival rates for a group of patients with ALL, a dramatic increase over the 1962 estimated survival rate of just 4 percent. * St. Jude pioneered the elimination of cranial irradiation in treating most leukemia patients, greatly reducing immediate and long-term effects in these patients (2009).* St. Jude was the first hospital in the world to perform gene therapy on a pediatric brain tumor patient (1995). * St. Jude discovered that sickle cell disease can be cured through a bone marrow transplant (1984). This is used in patients where the disease is so severe it justifies the inherent risks of a transplant.* St. Jude is currently engaged in the largest effort in the world to do whole genome sequencing of pediatric cancer tumors. Launched in 2010, the St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project holds promise for developing improved approaches to diagnosing and treating childhood cancers. Already, the project has generated more high-coverage, whole genome data than from all other sources combined.Unfortunately, what we still have to accomplish is acutely felt by our physicians and researchers every day: that there are still children who are not cured with today's best treatment. Until all children can be cured, we have not achieved our ultimate goal—to find cures to the diseases we treat so that no child shall die in the dawn of life.



GlobalGiving


GlobalGiving Badge not earned

GlobalGiving is the largest global crowdfunding community connecting nonprofits, donors, and companies in nearly every country. For donors, GlobalGiving provides an additional layer of vetting and due diligence for each of its nonprofit partners every two years, which may include site visit verification. Learn more about GlobalGiving.

Note: GlobalGiving Badges do not effect the nonprofit’s Impact & Results score.


...   Leadership & Adaptability


Charity Navigator will provide an assessment of the organization’s leadership capacity, strategic planning, and the ability to readily innovate or respond to changes in constituent demand/need or other relevant social and economic conditions to achieve the organization’s mission.


Leadership & Adaptability Score (BETA)

Coming Soon

Encompass Rating Beta V2 does not provide an evaluation of the organization's leadership and adaptability.


Back to Top

...   Culture & Community


Charity Navigator will provide an assessment of the organization’s people operations, connectedness and engagement with the constituents and communities served, and Diversity, Equity and Inclusion measures.


Culture & Community Score (BETA)

Coming Soon

Encompass Rating Beta V2 does not provide an evaluation of the organization's culture and community.


Back to Top